Orphan Drugs Market to Reach USD 340.84 Billion by 2027; Increasing Number of Regulatory Approvals will Contribute to Market Growth, says Fortune Business Insights™

NEXT STORY
Cerevel Therapeutics Announces the Appointments of Deval Patrick and Deborah Baron to its Board of Directors
PREV STORY
TELUS launches newest Health for Good mobile clinic to support Toronto’s most marginalized citizens
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

TiGenix announces acceptance of Cx601 abstract for oral presentation at 12th Congress of ECCO

  PRESS RELEASE   TiGenix announces acceptance of Cx601abstract for oral presentation at12th Congress of ECCO ...

author_avatar
NASDAQ Market News

CrownBio erweitert gentechnisch veränderte Modellauswahl durch strategische Partnerschaft mit dem Shanghai Model Organisms Center (SMOC)

Die Partnerschaft ermöglicht Forschern den Zugriff auf Tausende genetisch veränderter MausmodelleSAN DIEGO, Aug. 15, ...

author_avatar
NASDAQ Market News

Sublimity Therapeutics Appoints Jesse W. Hall as Chief Medical Officer

DUBLIN, Ireland, July 30, 2018 (GLOBE NEWSWIRE) -- Sublimity Therapeutics, a specialty pharmaceutical company ...

author_avatar
NASDAQ Market News